Effects of chronic chromium picolinate treatment in uninephrectomized rat

Mahmood S. Mozaffari, Champa Patel, Claudia Ballas, Stephen W. Schaffer

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Chromium picolinate [Cr(pic)3] is a nutritional supplement that is advocated as an adjuvant therapy for impaired glucose tolerance/type 2 diabetes because it improves glucose homeostasis. Because renal dysfunction is a major complication of type 2 diabetes, the potential impact of Cr(pic)3 on kidney function requires due consideration. This investigation takes added importance because the kidney is not only the principal route of elimination for chromium but also an organ that preferentially accumulates it. To avoid the confounding influence of chronic hyperglycemia, and its associated complications, we used the unilaterally nephrectomized (UNX) rat that shows impaired kidney function with age. We tested the hypothesis that chronic treatment of the UNX rat with Cr(pic)3 exacerbates the age-related decline in renal function. Accordingly, UNX rats were fed a diet lacking (eg, control; n = 5) or containing 5 mg/kg of Cr(pic)3 (n = 7) for 60 days. The treatment did not affect glucose tolerance as reflected by lack of any effect on changes in blood glucose concentration during glucose tolerance testing. Although nonfasting blood glucose concentrations were similar between the 2 groups, plasma insulin concentration was lower in the Cr(pic)3-treated group (P < .05), suggesting improved insulin sensitivity. Body weight, blood pressure, heart rate, daily food and fluid consumption, daily urinary fluid and electrolyte excretions, urine osmolality, and daily protein excretion were similar between the 2 groups before and during Cr(pic)3 treatment. Although renal excretory responses to acute administration of a 5% isotonic saline volume load were similar between the 2 groups, the Cr(pic)3-treated group displayed a more robust ability to excrete a 10% isotonic saline volume load, an effect primarily related to reduced tubular reabsorption of the filtered fluid and sodium loads. In conclusion, chronic Cr(pic)3 did not adversely affect renal function. Rather, the treatment improved the ability of the animal to dispose of an acute isotonic saline volume load, suggesting preservation of renal function in the UNX rat.

Original languageEnglish (US)
Pages (from-to)1243-1249
Number of pages7
JournalMetabolism: Clinical and Experimental
Volume54
Issue number9
DOIs
StatePublished - Sep 1 2005

Fingerprint

Kidney
Glucose
Type 2 Diabetes Mellitus
Blood Glucose
Glucose Intolerance
picolinic acid
Chromium
Hyperglycemia
Osmolar Concentration
Electrolytes
Insulin Resistance
Homeostasis
Heart Rate
Sodium
Body Weight
Urine
Insulin
Diet
Blood Pressure
Food

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Effects of chronic chromium picolinate treatment in uninephrectomized rat. / Mozaffari, Mahmood S.; Patel, Champa; Ballas, Claudia; Schaffer, Stephen W.

In: Metabolism: Clinical and Experimental, Vol. 54, No. 9, 01.09.2005, p. 1243-1249.

Research output: Contribution to journalArticle

Mozaffari, Mahmood S. ; Patel, Champa ; Ballas, Claudia ; Schaffer, Stephen W. / Effects of chronic chromium picolinate treatment in uninephrectomized rat. In: Metabolism: Clinical and Experimental. 2005 ; Vol. 54, No. 9. pp. 1243-1249.
@article{efde077c26114d1e8638269ced856cfc,
title = "Effects of chronic chromium picolinate treatment in uninephrectomized rat",
abstract = "Chromium picolinate [Cr(pic)3] is a nutritional supplement that is advocated as an adjuvant therapy for impaired glucose tolerance/type 2 diabetes because it improves glucose homeostasis. Because renal dysfunction is a major complication of type 2 diabetes, the potential impact of Cr(pic)3 on kidney function requires due consideration. This investigation takes added importance because the kidney is not only the principal route of elimination for chromium but also an organ that preferentially accumulates it. To avoid the confounding influence of chronic hyperglycemia, and its associated complications, we used the unilaterally nephrectomized (UNX) rat that shows impaired kidney function with age. We tested the hypothesis that chronic treatment of the UNX rat with Cr(pic)3 exacerbates the age-related decline in renal function. Accordingly, UNX rats were fed a diet lacking (eg, control; n = 5) or containing 5 mg/kg of Cr(pic)3 (n = 7) for 60 days. The treatment did not affect glucose tolerance as reflected by lack of any effect on changes in blood glucose concentration during glucose tolerance testing. Although nonfasting blood glucose concentrations were similar between the 2 groups, plasma insulin concentration was lower in the Cr(pic)3-treated group (P < .05), suggesting improved insulin sensitivity. Body weight, blood pressure, heart rate, daily food and fluid consumption, daily urinary fluid and electrolyte excretions, urine osmolality, and daily protein excretion were similar between the 2 groups before and during Cr(pic)3 treatment. Although renal excretory responses to acute administration of a 5{\%} isotonic saline volume load were similar between the 2 groups, the Cr(pic)3-treated group displayed a more robust ability to excrete a 10{\%} isotonic saline volume load, an effect primarily related to reduced tubular reabsorption of the filtered fluid and sodium loads. In conclusion, chronic Cr(pic)3 did not adversely affect renal function. Rather, the treatment improved the ability of the animal to dispose of an acute isotonic saline volume load, suggesting preservation of renal function in the UNX rat.",
author = "Mozaffari, {Mahmood S.} and Champa Patel and Claudia Ballas and Schaffer, {Stephen W.}",
year = "2005",
month = "9",
day = "1",
doi = "10.1016/j.metabol.2005.04.011",
language = "English (US)",
volume = "54",
pages = "1243--1249",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - Effects of chronic chromium picolinate treatment in uninephrectomized rat

AU - Mozaffari, Mahmood S.

AU - Patel, Champa

AU - Ballas, Claudia

AU - Schaffer, Stephen W.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Chromium picolinate [Cr(pic)3] is a nutritional supplement that is advocated as an adjuvant therapy for impaired glucose tolerance/type 2 diabetes because it improves glucose homeostasis. Because renal dysfunction is a major complication of type 2 diabetes, the potential impact of Cr(pic)3 on kidney function requires due consideration. This investigation takes added importance because the kidney is not only the principal route of elimination for chromium but also an organ that preferentially accumulates it. To avoid the confounding influence of chronic hyperglycemia, and its associated complications, we used the unilaterally nephrectomized (UNX) rat that shows impaired kidney function with age. We tested the hypothesis that chronic treatment of the UNX rat with Cr(pic)3 exacerbates the age-related decline in renal function. Accordingly, UNX rats were fed a diet lacking (eg, control; n = 5) or containing 5 mg/kg of Cr(pic)3 (n = 7) for 60 days. The treatment did not affect glucose tolerance as reflected by lack of any effect on changes in blood glucose concentration during glucose tolerance testing. Although nonfasting blood glucose concentrations were similar between the 2 groups, plasma insulin concentration was lower in the Cr(pic)3-treated group (P < .05), suggesting improved insulin sensitivity. Body weight, blood pressure, heart rate, daily food and fluid consumption, daily urinary fluid and electrolyte excretions, urine osmolality, and daily protein excretion were similar between the 2 groups before and during Cr(pic)3 treatment. Although renal excretory responses to acute administration of a 5% isotonic saline volume load were similar between the 2 groups, the Cr(pic)3-treated group displayed a more robust ability to excrete a 10% isotonic saline volume load, an effect primarily related to reduced tubular reabsorption of the filtered fluid and sodium loads. In conclusion, chronic Cr(pic)3 did not adversely affect renal function. Rather, the treatment improved the ability of the animal to dispose of an acute isotonic saline volume load, suggesting preservation of renal function in the UNX rat.

AB - Chromium picolinate [Cr(pic)3] is a nutritional supplement that is advocated as an adjuvant therapy for impaired glucose tolerance/type 2 diabetes because it improves glucose homeostasis. Because renal dysfunction is a major complication of type 2 diabetes, the potential impact of Cr(pic)3 on kidney function requires due consideration. This investigation takes added importance because the kidney is not only the principal route of elimination for chromium but also an organ that preferentially accumulates it. To avoid the confounding influence of chronic hyperglycemia, and its associated complications, we used the unilaterally nephrectomized (UNX) rat that shows impaired kidney function with age. We tested the hypothesis that chronic treatment of the UNX rat with Cr(pic)3 exacerbates the age-related decline in renal function. Accordingly, UNX rats were fed a diet lacking (eg, control; n = 5) or containing 5 mg/kg of Cr(pic)3 (n = 7) for 60 days. The treatment did not affect glucose tolerance as reflected by lack of any effect on changes in blood glucose concentration during glucose tolerance testing. Although nonfasting blood glucose concentrations were similar between the 2 groups, plasma insulin concentration was lower in the Cr(pic)3-treated group (P < .05), suggesting improved insulin sensitivity. Body weight, blood pressure, heart rate, daily food and fluid consumption, daily urinary fluid and electrolyte excretions, urine osmolality, and daily protein excretion were similar between the 2 groups before and during Cr(pic)3 treatment. Although renal excretory responses to acute administration of a 5% isotonic saline volume load were similar between the 2 groups, the Cr(pic)3-treated group displayed a more robust ability to excrete a 10% isotonic saline volume load, an effect primarily related to reduced tubular reabsorption of the filtered fluid and sodium loads. In conclusion, chronic Cr(pic)3 did not adversely affect renal function. Rather, the treatment improved the ability of the animal to dispose of an acute isotonic saline volume load, suggesting preservation of renal function in the UNX rat.

UR - http://www.scopus.com/inward/record.url?scp=23944508545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944508545&partnerID=8YFLogxK

U2 - 10.1016/j.metabol.2005.04.011

DO - 10.1016/j.metabol.2005.04.011

M3 - Article

C2 - 16125537

AN - SCOPUS:23944508545

VL - 54

SP - 1243

EP - 1249

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 9

ER -